Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis | Zendy

Mark Lebwohl | Zendy; Linda Stein Gold | Zendy; Bruce Strober | Zendy; Kim Papp | Zendy; April W. Armstrong | Zendy; Jerry Bagel | Zendy; Leon Kircik | Zendy; Benjamin D. Ehst | Zendy; Hwanhee Hong | Zendy; Jennifer Soung | Zendy; Jeff Fromowitz | Zendy; Scott Guenthner | Zendy; Stephen C. Piscitelli | Zendy; David S. Rubenstein | Zendy; Philip M. Brown | Zendy; Anna M. Tallman | Zendy; Robert Bissonnette | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

Author(s) -

Mark Lebwohl,

Linda Stein Gold,

Bruce Strober,

Kim Papp,

April W. Armstrong,

Jerry Bagel,

Leon Kircik,

Benjamin D. Ehst,

Hwanhee Hong,

Jennifer Soung,

Jeff Fromowitz,

Scott Guenthner,

Stephen C. Piscitelli,

David S. Rubenstein,

Philip M. Brown,

Anna M. Tallman,

Robert Bissonnette

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2103629

Subject(s) - medicine , plaque psoriasis , psoriasis , dermatology , medline , political science , law

Tapinarof cream is a topical aryl hydrocarbon receptor-modulating agent under investigation for the treatment of psoriasis. Tapinarof modulates the expression of interleukin-17 and the skin-barrier proteins filaggrin and loricrin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore